Our own Kelly Close moderates a panel at SXSW Interactive.

Sept. 28 was a big day for diabetes tech approvals in the US – a big step in bringing the latest and greatest tech to people with diabetes!

Free for patients! Initially available in Austria and Germany, and soon in the US.

Significant Improvement in A1c and time-in-range when adding CGM.

Plus, a partnership with UCSF to drive better research.

Available in US physicians’ offices in the next couple weeks; Real-time version submitted to FDA!

Details for Dexcom July 21 Advisory Panel meeting posted. How to submit a written statement to the FDA or attend in person.

Adam Brown leads expert panel discussion at The diaTribe Foundation’s first-ever digital health gathering at ADA 2016.

Data from Bluetooth-enabled meter can now be shared with other health tracking apps.

Coming to US in Spring 2017: What it is, what it isn’t, and how to get it

Providers and patients will now see the same data - stay tuned for IBM Watson!

The Annual TCOYD/The diaTribe Foundation Forum Celebrates its 10 th Anniversary in New Orleans

Plus, Lilly invests $5 million! We talk to Dr. Ed Damiano to learn about the new Gen 3 version and upcoming studies.

$99 device makes pump and CGM data viewable to Android smartphone users. Plus, a first look at cool pattern recognition in the Sugar.IQ app with IBM Watson

Launching this June in Sweden, followed by Norway and Denmark. How does it compare to current CGM?

An 8-2 panel vote finds that benefits of using Dexcom’s G5 CGM for dosing insulin outweigh the risks; patient advocates provide compelling testimonies

Recruiting participants in Boston at the Joslin Diabetes Center

New improvements in the second-generation: better battery, app control, and more!

Matchstick-sized device implanted under the skin every 6-12 months. New data in over 4,000 people demonstrates it is safe for heart health. Could it launch by late 2017?

What does A1c miss and what can we do about it?